The new hepatitis C era: the guidelines are now available, reimbursement not yet...
Department of Internal Medicine, Division of Infectious Diseases, Erasmus University Medical Center Rotterdam, the Netherlands.
S J
SJ
Hullegie
B J A
BJ
Rijnders
D000998:Antiviral Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D006526:Hepatitis C / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics; D009426:Netherlands; D017410:Practice Guidelines as Topic; D019057:Quality-Adjusted Life Years
D000998:Antiviral Agents